サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386503

先進治療医薬品市場レポート：2030年までの動向、予測、競合分析

Advanced Therapy Medicinal Products Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

先進治療医薬品市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月11日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

先進治療医薬品の動向と予測

世界の先進治療医薬品市場は、2024年から2030年までのCAGRが13.5%で、2030年までに推定199億米ドルに達すると予想されます。この市場の主な促進要因は、ヘルスケア支出の増加、慢性疾患の有病率の増加、良好な規制環境と政府支援の拡大です。細胞療法、CAR-T療法、遺伝子療法、組織工学製品市場にビジネスチャンスがあり、世界の先進治療医薬品市場の将来は有望です。

先進治療医薬品市場の洞察

Lucintelは、組織工学製品は創傷治癒と再生医療用途での採用が増加しているため、最大セグメントであり続けると予測しています。

北米は、がん、心血管疾患、神経変性疾患などの慢性疾患の有病率が高いため、最大セグメントであり続ける。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どの分野がより速いペースで成長するか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界の先進治療医薬品市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の先進治療医薬品市場動向（2018～2023年）と予測（2024～2030年）
  • 製品別の世界の先進治療医薬品市場
    • 細胞治療
    • CAR-T療法
    • 遺伝子治療
    • 組織工学加工製品

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の先進治療医薬品市場
  • 北米の先進治療医薬品市場
  • 欧州の先進治療医薬品市場
  • アジア太平洋の先進治療医薬品市場
  • その他地域先進治療医薬品市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 製品別の世界の先進治療医薬品市場の成長機会
    • 地域別の世界の先進治療医薬品市場の成長機会
  • 世界の先進治療医薬品市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の先進治療医薬品市場の能力拡大
    • 世界の先進治療医薬品市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • UniQure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon TissueGene
  • JCR Pharmaceuticals
  • MEDIPOST
  • Vericel Corporation
目次

Advanced Therapy Medicinal Products Trends and Forecast

The future of the global advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets. The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases, and favorable regulatory environment and growing government support.

A more than 150-page report is developed to help in your business decisions.

Advanced Therapy Medicinal Products by Segment

The study includes a forecast for the global advanced therapy medicinal products by product and region.

Advanced Therapy Medicinal Products Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Therapy
  • CAR-T Therapy
  • Gene Therapy
  • Tissue Engineered Product

Advanced Therapy Medicinal Products Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Advanced Therapy Medicinal Products Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies advanced therapy medicinal products companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the advanced therapy medicinal products companies profiled in this report include-

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation

Advanced Therapy Medicinal Products Market Insights

Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Features of the Global Advanced Therapy Medicinal Products Market

Market Size Estimates: Advanced therapy medicinal products market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Advanced therapy medicinal products size by product and region in terms of value ($B).

Regional Analysis: Advanced therapy medicinal products market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products and regions for the mucopolysaccharidosis treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the advanced therapy medicinal products market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the advanced therapy medicinal products market size?

Answer: The global advanced therapy medicinal products market is expected to reach an estimated $19.9 billion by 2030.

Q.2 What is the growth forecast for advanced therapy medicinal products market?

Answer: The global advanced therapy medicinal products market is expected to grow with a CAGR of 13.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the advanced therapy medicinal products market?

Answer: The major drivers for this market are rising healthcare spending, increasing prevalence of chronic diseases and favorable regulatory environment and growing government support.

Q4. What are the major segments for advanced therapy medicinal products market?

Answer: The future of the advanced therapy medicinal products market looks promising with opportunities in the cell therapy, CAR-T therapy, gene therapy, and tissue engineered product markets.

Q5. Who are the key advanced therapy medicinal products market companies?

Answer: Some of the key advanced therapy medicinal products companies are as follows:

  • Spark Therapeutics
  • Bluebird Bio
  • Novartis
  • Uniqure
  • Celgene Corporation
  • Gilead Lifesciences
  • Kolon Tissuegene
  • JCR Pharmaceuticals
  • Medipost
  • Vericel Corporation

Q6. Which advanced therapy medicinal products market segment will be the largest in future?

Answer: Lucintel forecasts that tissue engineered product will remain the largest segment due to its increasing adoption in wound healing and regenerative medicine applications.

Q7. In advanced therapy medicinal products market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment due to high prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the advanced therapy medicinal products market by product (cell therapy, CAR-T therapy, gene therapy, and tissue engineered product), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Advanced Therapy Medicinal Products Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Advanced Therapy Medicinal Products Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Advanced Therapy Medicinal Products Market by Product
    • 3.3.1: Cell Therapy
    • 3.3.2: CAR-T Therapy
    • 3.3.3: Gene Therapy
    • 3.3.4: Tissue Engineered Product

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Advanced Therapy Medicinal Products Market by Region
  • 4.2: North American Advanced Therapy Medicinal Products Market
  • 4.3: European Advanced Therapy Medicinal Products Market
    • 4.3.1: European Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
  • 4.4: APAC Advanced Therapy Medicinal Products Market
    • 4.4.1: APAC Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product
  • 4.5: ROW Advanced Therapy Medicinal Products Market
    • 4.5.1: ROW Advanced Therapy Medicinal Products Market by Product: Cell Therapy, CAR-T Therapy, Gene Therapy, and Tissue Engineered Product

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Product
    • 6.1.2: Growth Opportunities for the Global Advanced Therapy Medicinal Products Market by Region
  • 6.2: Emerging Trends in the Global Advanced Therapy Medicinal Products Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Advanced Therapy Medicinal Products Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Advanced Therapy Medicinal Products Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Spark Therapeutics
  • 7.2: Bluebird Bio
  • 7.3: Novartis
  • 7.4: UniQure
  • 7.5: Celgene Corporation
  • 7.6: Gilead Lifesciences
  • 7.7: Kolon TissueGene
  • 7.8: JCR Pharmaceuticals
  • 7.9: MEDIPOST
  • 7.10: Vericel Corporation